只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-10 2026-07-14 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire Director,Officer · Chief Executive Officer | 卖出（S） | 9,972 | US$28.42 | US$283,367.34 | 362,180 | SEC |
| 2026-07-10 2026-07-14 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire Director,Officer · Chief Executive Officer | 卖出（S） | 28 | US$29.68 | US$831.04 | 362,152 | SEC |
| 2026-07-09 2026-07-10 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan Director,Officer · President and COO | 卖出（S） | 536 | US$29.00 | US$15,544.00 | 181,641 | SEC |
| 2026-07-08 2026-07-10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan Officer · Chief Financial Officer | 卖出（S） | 22,757 | US$28.60 | US$650,895.71 | 135,098 | SEC |
| 2026-07-08 2026-07-10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan Officer · Chief Financial Officer | 卖出（S） | 4,413 | US$29.82 | US$131,615.96 | 130,685 | SEC |
| 2026-07-08 2026-07-10 | BCAX Bicara Therapeutics Inc. | Hyep Ivan Officer · Chief Financial Officer | 卖出（S） | 830 | US$30.31 | US$25,160.29 | 129,855 | SEC |
| 2026-07-08 2026-07-10 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan Director,Officer · President and COO | 卖出（S） | 22,833 | US$28.76 | US$656,651.96 | 187,558 | SEC |
| 2026-07-08 2026-07-10 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan Director,Officer · President and COO | 卖出（S） | 4,306 | US$29.80 | US$128,302.01 | 183,252 | SEC |
| 2026-07-08 2026-07-10 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan Director,Officer · President and COO | 卖出（S） | 1,075 | US$30.35 | US$32,631.52 | 182,177 | SEC |
| 2026-05-21 2026-05-26 | BCAX Bicara Therapeutics Inc. | Hyep Ivan Officer · Chief Financial Officer | 卖出（S） | 9,200 | US$20.42 | US$187,864.00 | 145,355 | SEC |
| 2026-05-18 2026-05-20 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire Director,Officer · Chief Executive Officer | 卖出（S） | 12,022 | US$19.96 | US$239,959.12 | 365,130 | SEC |
| 2026-05-18 2026-05-20 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire Director,Officer · Chief Executive Officer | 卖出（S） | 2,978 | US$20.35 | US$60,602.30 | 362,152 | SEC |
| 2026-05-15 2026-05-18 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan Director,Officer · President and COO | 卖出（S） | 8,000 | US$20.29 | US$162,320.00 | 196,141 | SEC |
| 2026-05-15 2026-05-18 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan Director,Officer · President and COO | 卖出（S） | 4,500 | US$20.29 | US$91,305.00 | 191,641 | SEC |
| 2026-04-27 2026-04-28 | BCAX Bicara Therapeutics Inc. | Raben David Officer · Chief Medical Officer | 卖出（S） | 5,500 | US$22.88 | US$125,840.00 | 55,286 | SEC |
| 2026-04-21 2026-04-22 | BCAX Bicara Therapeutics Inc. | Hyep Ivan Officer · Chief Financial Officer | 卖出（S） | 9,200 | US$23.00 | US$211,600.00 | 145,355 | SEC |
| 2026-04-20 2026-04-20 | BCAX Bicara Therapeutics Inc. | Mazumdar Claire Director,Officer · Chief Executive Officer | 卖出（S） | 15,000 | US$23.61 | US$354,150.00 | 362,152 | SEC |
| 2026-04-15 2026-04-17 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan Director,Officer · President and COO | 卖出（S） | 4,500 | US$23.01 | US$103,545.00 | 196,141 | SEC |
| 2026-04-15 2026-04-17 | BCAX Bicara Therapeutics Inc. | Cohlhepp Ryan Director,Officer · President and COO | 卖出（S） | 8,000 | US$23.01 | US$184,080.00 | 200,641 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| BCAX | 78,519.6197 | 0 | 273,060.9344 | 28.76% | B, Q, N |